KRAS and non-small cell lung carcinoma: Interestingly, while low let-7 expression and KRas mutation expectedly predict poor survival126,131, a variant KRas, KRas-LCS6, is associated with increased risk of developing NSCLC and reduced survival in HNSCC132,.133